Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.53M | 3.94M | 4.95M | 4.19M | 2.15M | 0.00 | Gross Profit |
508.51K | 2.90M | 2.87M | 2.65M | 1.20M | 0.00 | EBIT |
-5.24M | -3.35M | -979.92K | 648.35K | 10.64K | -15.64K | EBITDA |
-4.80M | -2.79M | -1.63M | 1.01M | 37.05K | 0.00 | Net Income Common Stockholders |
-5.55M | -3.32M | -1.01M | 584.39K | 10.64K | -15.64K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
0.00 | 6.20M | 12.18M | 615.75K | 326.71K | 0.00 | Total Assets |
495.15K | 15.12M | 19.69M | 6.86M | 7.48M | 495.15K | Total Debt |
0.00 | 597.14K | 832.07K | 1.09M | 1.35M | 0.00 | Net Debt |
0.00 | -5.60M | -11.35M | 470.97K | 1.02M | 0.00 | Total Liabilities |
5.28K | 1.19M | 2.20M | 1.30M | 2.20M | 5.28K | Stockholders Equity |
489.87K | 13.93M | 17.49M | 5.56M | 5.29M | 489.87K |
Cash Flow | Free Cash Flow | ||||
-8.82M | -5.96M | -782.63K | 1.15M | -5.58M | -505.51K | Operating Cash Flow |
-8.37M | -5.47M | -736.97K | 1.38M | -1.33M | -505.51K | Investing Cash Flow |
-447.85K | -484.86K | -45.66K | -229.47K | -4.26M | 0.00 | Financing Cash Flow |
2.63M | -25.24K | 12.35M | -856.79K | 5.91M | 505.51K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $5.69B | 25.30 | 9.50% | 1.05% | -1.14% | ― | |
68 Neutral | $12.20B | ― | 1.25% | ― | 21.68% | 92.07% | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.39% | 3.96% | -12.36% | |
62 Neutral | $2.75B | ― | -9.17% | ― | -20.08% | -218.29% | |
58 Neutral | $5.26B | ― | -42.79% | ― | 3.58% | -22.74% | |
52 Neutral | $66.58M | ― | -9.50% | ― | 21.44% | -8.49% | |
50 Neutral | $37.13M | ― | -30.59% | ― | -44.07% | -78.93% |
Laser Photonics Corporation has acquired Control Micro Systems to expand its market reach into the pharmaceutical industry, leveraging CMS’s precision laser solutions for controlled-release medications. This strategic move allows Laser Photonics to diversify into a recession-resistant sector, enhance its technological capabilities, and capitalize on growing demand for laser-based drug delivery and packaging compliance solutions. The acquisition also promises a seamless transition for CMS’s workforce and continued service for existing customers.